Coty's Turnaround Narrative Hinges on Whether Vendors Keep Waiting
Coty Inc. reports fiscal third-quarter 2026 earnings tomorrow, May 5, after market close, with analysts expecting the global beauty company to post break-even results amid a challenging turnaround. The report arrives at a critical juncture: COTY has missed earnings estimates in each of the past four quarters—sometimes dramatically—while the stock trades 29% below its 200-day moving average and analyst sentiment remains decidedly cautious. Investors will scrutinize whether management can stabilize performance across its prestige fragrance and mass-market cosmetics portfolio, or if the string of disappointments will extend into a fifth consecutive quarter.
Part 1: Earnings Preview
Coty Inc. is a global beauty company operating across fragrances, cosmetics, and skin & body care with a portfolio spanning mass-market brands like CoverGirl and Rimmel alongside prestige licenses including Gucci Beauty, Marc Jacobs, and Kylie Cosmetics. The company sells products in over 130 countries and focuses on premiumization, e-commerce expansion, and strengthening core brands through innovation and strategic licensing deals.
Coty reports fiscal Q3 2026 results tomorrow after market close, with the consensus calling for $0.00 EPS on revenue of approximately $1.30 billion. The most recent quarter (Q2 2026, reported February 5) delivered $0.14 per share, missing the $0.18 estimate by 22%. Year-over-year context shows no improvement: the company posted $0.01 per share in Q3 2025, meaning analysts expect flat earnings despite a full year to execute the turnaround.
Three narrative themes dominate this earnings story. Turnaround Credibility sits at the forefront—after four consecutive misses ranging from 20% to 600%, investors need evidence that management's restructuring efforts are gaining traction rather than merely buying time. Portfolio Performance Divergence matters because prestige fragrances have historically driven growth while mass-market cosmetics struggle; the balance between these segments will signal whether premiumization is working or if weakness is spreading. Margin Pressure and Cash Flow rounds out the picture, as gross margin trends and free cash flow generation determine whether COTY can reduce its debt burden and fund the innovation pipeline without diluting shareholders.
Analyst commentary ahead of the release reflects deep skepticism. The consensus has deteriorated sharply over 90 days, with EPS estimates for this quarter collapsing from $0.07 to $0.00 and full-year 2026 estimates dropping from $0.43 to $0.24. Revenue projections have similarly declined, with this quarter's estimate falling 1.9% year-over-year. One analyst noted that "the company is counting on ordinary Americans never reading a 93-page document," suggesting transparency concerns, while another warned that "drilling has begun but the market hasn't fully caught on," hinting at operational challenges not yet reflected in the stock price. The technical opinion has shifted from 100% Sell a month ago to 40% Sell today, indicating some short-term stabilization but persistent medium- and long-term weakness.
Part 2: Historical Earnings Performance
Coty's earnings history reveals a company in persistent distress, missing analyst estimates in all four of the past quarters with an average miss of 180%. The pattern shows no signs of improvement: Q3 2025 missed by 80%, Q4 2025 missed by a staggering 600% (posting a loss of $0.05 versus a $0.01 profit estimate), Q1 2026 missed by 20%, and Q2 2026 missed by 22%. The magnitude of these misses has been severe, with the Q4 2025 result particularly alarming as the company swung to a loss when analysts expected profitability.
The trend is unambiguously negative. Reported earnings have deteriorated from $0.01 in Q3 2025 to $0.14 in Q2 2026, but even that sequential improvement masks the fact that Q2 results fell short of the $0.18 estimate. More concerning, estimates themselves have collapsed—what analysts once projected as $0.05 for Q3 2025 turned into $0.01 actual, and the current quarter's $0.00 consensus reflects capitulation rather than confidence. The consistency of underperformance suggests either systematic operational challenges or persistent over-optimism from management guidance that analysts have been slow to discount.
| Quarter | EPS Estimate | EPS Actual | Surprise % | Beat/Miss |
|---|---|---|---|---|
| Mar 2025 | $0.05 | $0.01 | -80.00% | Miss |
| Jun 2025 | $0.01 | $-0.05 | -600.00% | Miss |
| Sep 2025 | $0.15 | $0.12 | -20.00% | Miss |
| Dec 2025 | $0.18 | $0.14 | -22.22% | Miss |
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
Coty typically reports after market close, meaning Day 0 reflects anticipatory trading before results are known, while Day +1 captures the market's first full reaction to the actual numbers.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-02-05 | -$0.28 (-8.16%) | $0.35 (10.35%) | -$0.49 (-15.56%) | $0.48 (15.24%) |
| 2025-11-05 | -$0.05 (-1.31%) | $0.11 (3.00%) | -$0.06 (-1.59%) | $0.48 (12.57%) |
| 2025-08-20 | -$0.03 (-0.61%) | $0.16 (3.27%) | -$1.05 (-21.60%) | $0.21 (4.32%) |
| 2025-05-06 | +$0.01 (+0.19%) | $0.13 (2.52%) | -$0.60 (-11.61%) | $0.43 (8.32%) |
| 2025-02-10 | +$0.01 (+0.15%) | $0.18 (2.66%) | -$0.63 (-9.31%) | $0.97 (14.33%) |
| 2024-11-06 | -$0.11 (-1.46%) | $0.29 (3.85%) | -$0.18 (-2.42%) | $0.42 (5.65%) |
| 2024-08-20 | -$0.02 (-0.21%) | $0.13 (1.36%) | +$0.60 (+6.30%) | $0.63 (6.61%) |
| 2024-05-06 | -$0.10 (-0.86%) | $0.39 (3.41%) | -$0.40 (-3.48%) | $0.64 (5.61%) |
| Avg Abs Move | 1.62% | 3.80% | 8.98% | 9.08% |
Historical price behavior around Coty earnings shows significant volatility, with an average absolute Day +1 move of 8.98% and Day +1 range of 9.08%—substantially larger than the Day 0 anticipation move of 1.62%. The most recent four reports demonstrate the pattern clearly: February 2026 saw a 15.56% decline the day after results, August 2025 dropped 21.60%, May 2025 fell 11.61%, and February 2025 declined 9.31%. Only one of the past eight earnings releases (August 2024) produced a positive Day +1 move, gaining 6.30%. The data reveals a stock that tends to trade quietly into the print but reacts violently afterward, with downside moves dominating as the string of estimate misses has eroded investor confidence. Investors should prepare for potential double-digit percentage swings in either direction, though recent history heavily favors downside given the consistent disappointments.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 05/15/26 (DTE 11) |
| Expected Move | $0.45 (18.62%) |
| Expected Range | $1.97 to $2.87 |
| Implied Volatility | 134.43% |
The options market is pricing an 18.62% expected move through the May 15 expiration (11 days out), which is roughly double the 8.98% average historical Day +1 move but consistent with the elevated volatility seen in recent reports like February 2026 (15.56% decline) and August 2025 (21.60% decline). The implied move range of $1.97 to $2.87 suggests options traders are bracing for another significant reaction, reflecting the uncertainty around whether management can finally deliver results that meet expectations after four consecutive misses.
Part 3: What Analysts Are Saying
Analyst sentiment toward Coty remains decidedly cautious, with the consensus rating at 2.88 (between Sell and Hold) and an average price target of $3.31—implying 37% upside from the current $2.42 price, though that target has likely not kept pace with the stock's recent decline. The breakdown shows skepticism dominates: of 17 analysts covering the stock, 14 rate it Hold, 1 Moderate Buy, 1 Moderate Sell, and 1 Strong Sell. Notably, zero analysts rate COTY a Strong Buy, underscoring the lack of conviction even among those willing to recommend the shares.
Sentiment has remained unchanged over the past month according to the precomputed trend, but the stability masks underlying deterioration in estimates. While the rating distribution hasn't shifted, analysts have slashed earnings projections dramatically—current-quarter estimates fell from $0.07 three months ago to $0.00 today, and full-year 2026 estimates dropped from $0.43 to $0.24 over the same period. The price target range is exceptionally wide, spanning from $1.50 to $8.00, reflecting deep disagreement about the company's prospects. The low-end target sits 38% below current levels, while the high-end implies more than 3x upside—a spread that suggests some analysts see potential in the turnaround while others view the business as fundamentally impaired. The consensus appears to be waiting for proof of execution before upgrading, making tomorrow's results critical for shifting the narrative.
Part 4: Technical Picture
Coty's technical setup heading into earnings reflects a stock attempting to stabilize after a prolonged decline but still trapped well below key resistance levels. The Barchart Technical Opinion currently reads 40% Sell, an improvement from 56% Sell one week ago and 100% Sell one month ago, indicating some short-term momentum recovery even as deeper structural weakness persists.
Timeframe Analysis:
- Short-term (Hold): Neutral signal suggests the immediate downtrend has paused, giving the stock room to consolidate ahead of the earnings catalyst
- Medium-term (50% Sell): Moderate sell signal indicates the intermediate trend remains under pressure despite recent stabilization
- Long-term (100% Sell): Strong sell signal confirms the broader trend is decisively negative, with the stock deeply oversold on longer timeframes
Trend Characteristics: The combination of Good strength and Weakest direction suggests the stock is exhibiting clear technical patterns, but those patterns point firmly downward—a setup that offers little cushion if earnings disappoint again.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $2.43 | 50-Day MA | $2.29 |
| 10-Day MA | $2.40 | 100-Day MA | $2.68 |
| 20-Day MA | $2.32 | 200-Day MA | $3.41 |
The stock trades at $2.42, positioned above its 10-day ($2.40), 20-day ($2.32), and 50-day ($2.29) moving averages, indicating short-term momentum has turned positive. However, COTY remains below its 100-day ($2.68) and 200-day ($3.41) moving averages, with the 200-day sitting 41% above current levels and serving as formidable resistance. The recent bounce off the 50-day average suggests buyers are defending that support zone, but the stock's failure to reclaim the 100-day average keeps the intermediate trend bearish. Heading into earnings, the technical picture is cautiously constructive for a short-term trade but offers no safety net if results trigger another leg down—the 18.62% options-implied move could easily erase the recent gains and test new lows if the fifth consecutive miss materializes. The setup favors nimble traders over long-term holders until the company can prove it has turned the corner operationally.